|
| BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by nextgeneration sequencing |
|
https://doi.org/10.18632/oncotarget.6834
Andrea Mafficini, Michele Simbolo, Alice Parisi, Borislav Rusev, Claudio Luchini, Ivana Cataldo, Elena Piazzola, Nicola Sperandio, Giona Turri, Massimo Franchi, Giampaolo Tortora, Chiara Bovo, Rita T. Lawlor, and Aldo Scarpa
|
| 1076-1083 |
|
| Kupffer cellsdependent inflammation in the injured liver increases recruitment of mesenchymal stem cells in aging mice |
|
https://doi.org/10.18632/oncotarget.6744
Xue Yang, Lei Liang, Chen Zong, Fobao Lai, Pengxi Zhu, Yu Liu, Jinghua Jiang, Yang Yang, Lu Gao, Fei Ye, Qiudong Zhao, Rong Li, Zhipeng Han, and Lixin Wei
|
| 1084-1095 |
|
| Microbiota and bile acid profiles in retinoic acidprimed mice that exhibit accelerated liver regeneration |
|
https://doi.org/10.18632/oncotarget.6665
Hui-Xin Liu, Ying Hu, and Yu-Jui Yvonne Wan
|
| 1096-1106 |
|
| Altered expression of epithelialtomesenchymal transition proteins in extraprostatic prostate cancer |
|
https://doi.org/10.18632/oncotarget.6689
Clare Verrill, Lucia Cerundolo, Chad Mckee, Michael White, Christiana Kartsonaki, Eve Fryer, Emma Morris, Simon Brewster, Indrika Ratnayaka, Luke Marsden, Hans Lilja, Ruth Muschel, Xin Lu, Freddie Hamdy, and Richard J. Bryant
|
| 1107-1119 |
|
| The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signaling |
|
https://doi.org/10.18632/oncotarget.6683
Erna Raja, Kalliopi Tzavlaki, Robin Vuilleumier, Karolina Edlund, Kaoru Kahata, Agata Zieba, Anita Morén, Yukihide Watanabe, Iryna Voytyuk, Johan Botling, Ola Söderberg, Patrick Micke, George Pyrowolakis, Carl-Henrik Heldin, and Aristidis Moustakas
|
| 1120-1143 |
|
| Assessing sirtuin expression in endometrial carcinoma and nonneoplastic endometrium |
|
https://doi.org/10.18632/oncotarget.6691
Carla Bartosch, Sara Monteiro-Reis, Diogo Almeida-Rios, Renata Vieira, Armando Castro, Manuel Moutinho, Marta Rodrigues, Inês Graça, José Manuel Lopes, and Carmen Jerónimo
|
| 1144-1154 |
|
| Mitoguardin1 and 2 promote maturation and the developmental potential of mouse oocytes by maintaining mitochondrial dynamics and functions |
|
https://doi.org/10.18632/oncotarget.6713
Xiao-Man Liu, Yong-Ping Zhang, Shu-Yan Ji, Bo-Tai Li, Xuejun Tian, Dali Li, Chao Tong, and Heng-Yu Fan
|
| 1155-1167 |
|
| Activated T cells sustain myeloidderived suppressor cellmediated immune suppression |
|
https://doi.org/10.18632/oncotarget.6662
Laura Pinton, Samantha Solito, Vera Damuzzo, Samuela Francescato, Assunta Pozzuoli, Antonio Berizzi, Simone Mocellin, Carlo Riccardo Rossi, Vincenzo Bronte, and Susanna Mandruzzato
|
| 1168-1184 |
|
| Ineffectiveness of the 20142015 H3N2 influenza vaccine |
|
https://doi.org/10.18632/oncotarget.6746
Michal Mandelboim, Aharona Glatman-Freedman, Yaron Drori, Hilda Sherbany, Rakefet Pando, Hanna Sefty, Hila Zadka, Tamar Shohat, Nathan Keller, and Ella Mendelson
|
| 1185-1192 |
|
| Can active components of licorice glycyrrhizin and glycyrrhetinic acid lick rheumatoid arthritis |
|
https://doi.org/10.18632/oncotarget.6200
Qing-Chun Huang, Mao-Jie Wang, Xiu-Min Chen, Wan-Lin Yu, Yong-Liang Chu, Xiao-Hong He, and Run-Yue Huang
|
| 1193-1202 |
|
| CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.6209
Qingan Jia, Qiongzhu Dong, and Lunxiu Qin
|
| 1203-1214 |
|
| Tumorsphere as an effective in vitro platform for screening anticancer stem cell drugs |
|
https://doi.org/10.18632/oncotarget.6261
Che-Hsin Lee, Cheng-Chia Yu, Bing-Yen Wang, and Wen-Wei Chang
|
| 1215-1226 |
|
| Fisetin a dietary flavonoid augments the antiinvasive and antimetastatic potential of sorafenib in melanoma |
|
https://doi.org/10.18632/oncotarget.6237
Harish C. Pal, Ariana C. Diamond, Leah R. Strickland, John C. Kappes, Santosh K. Katiyar, Craig A. Elmets, Mohammad Athar, and Farrukh Afaq
|
| 1227-1241 |
|
| Novel p53dependent anticancer strategy by targeting iron signaling and BNIP3Linduced mitophagy |
|
https://doi.org/10.18632/oncotarget.6233
Nastasia Wilfinger, Shane Austin, Barbara Scheiber-Mojdehkar, Walter Berger, Siegfried Reipert, Monika Praschberger, Jakob Paur, Robert Trondl, Bernhard K. Keppler, Christoph C. Zielinski, and Karin Nowikovsky
|
| 1242-1261 |
|
| Leptin as a mediator of tumorstromal interactions promotes breast cancer stem cell activity |
|
https://doi.org/10.18632/oncotarget.6014
Cinzia Giordano, Francesca Chemi, Salvatore Panza, Ines Barone, Daniela Bonofiglio, Marilena Lanzino, Angela Cordella, Antonella Campana, Adnan Hashim, Pietro Rizza, Antonella Leggio, Balázs Győrffy, Bruno M. Simões, Robert B. Clarke, Alessandro Weisz, Stefania Catalano, and Sebastiano Andò
|
| 1262-1275 |
|
| MicroRNA152mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis |
|
https://doi.org/10.18632/oncotarget.6004
Iryna Kindrat, Volodymyr Tryndyak, Aline de Conti, Svitlana Shpyleva, Thilak K. Mudalige, Tetyana Kobets, Anna M. Erstenyuk, Frederick A. Beland, and Igor P. Pogribny
|
| 1276-1287 |
|
| MiR630 suppresses breast cancer progression by targeting metadherin |
|
https://doi.org/10.18632/oncotarget.6339
Ci-Xiang Zhou, Chen-Long Wang, An-Lu Yu, Qiu-Yu Wang, Meng-Na Zhan, Jun Tang, Xiu-Feng Gong, Qian-Qian Yin, Ming He, Jian-Rong He, Guo-Qiang Chen, and Qian Zhao
|
| 1288-1299 |
|
| A PCA3 genebased transcriptional amplification system targeting primary prostate cancer |
|
https://doi.org/10.18632/oncotarget.6360
Bertrand Neveu, Pallavi Jain, Bernard Têtu, Lily Wu, Yves Fradet, and Frédéric Pouliot
|
| 1300-1310 |
|
| NDRG4 stratifies the prognostic value of body mass index in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.6182
Jianyong Zheng, Yunming Li, Shaojun Zhu, Jipeng Li, Qingchuan Zhao, Gang Ji, Weizhong Wang, and Dake Chu
|
| 1311-1322 |
|
| Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the proapoptotic NFκB |
|
https://doi.org/10.18632/oncotarget.6361
Francesca Buontempo, Ester Orsini, Annalisa Lonetti, Alessandra Cappellini, Francesca Chiarini, Camilla Evangelisti, Cecilia Evangelisti, Fraia Melchionda, Andrea Pession, Alice Bertaina, Franco Locatelli, Jessika Bertacchini, Luca Maria Neri, James A. McCubrey, and Alberto Maria Martelli
|
| 1323-1340 |
|
| Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals |
|
https://doi.org/10.18632/oncotarget.6372
Hongjun Xie, Chong Li, Qiang Dang, Luke S. Chang, and Lei Li
|
| 1341-1353 |
|
| Diverse in vivo effects of soluble and membranebound MCSF on tumorassociated macrophages in lymphoma xenograft model |
|
https://doi.org/10.18632/oncotarget.6362
Jinfeng Liao, Wenli Feng, Rong Wang, Shihui Ma, Lina Wang, Xiao Yang, Feifei Yang, Yongmin Lin, Qian Ren, and Guoguang Zheng
|
| 1354-1366 |
|
| KIT overexpression by p55PIKPI3K leads to Imatinibresistance in patients with gastrointestinal stromal tumors |
|
https://doi.org/10.18632/oncotarget.6011
Senyan Lai, Guihua Wang, Xiaonian Cao, Xuelai Luo, Guoping Wang, Xianmin Xia, Junbo Hu, and Jing Wang
|
| 1367-1379 |
|
| A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK8776 as monotherapy due to CDK2 activation in S phase |
|
https://doi.org/10.18632/oncotarget.6364
Nandini Sakurikar, Ruth Thompson, Ryan Montano, and Alan Eastman
|
| 1380-1394 |
|
| Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia AML cell growth |
|
https://doi.org/10.18632/oncotarget.6366
Lijun Qin, Yun Tian, Zhenlong Yu, Dingbo Shi, Jingshu Wang, Changlin Zhang, Ruoyu Peng, Xuezhen Chen, Congcong Liu, Yiming Chen, Wenlin Huang, and Wuguo Deng
|
| 1395-1407 |
|
| Epigenetic repression of PDZLIM domaincontaining protein 2 promotes ovarian cancer via NOS2derived nitric oxide signaling |
|
https://doi.org/10.18632/oncotarget.6368
Linjie Zhao, Chuan Yu, Shengtao Zhou, Wayne Bond Lau, Bonnie Lau, Zhongyue Luo, Qiao Lin, Huiliang Yang, Yu Xuan, Tao Yi, Xia Zhao, and Yuquan Wei
|
| 1408-1420 |
|
| Integration of tissue metabolomics transcriptomics and immunohistochemistry reveals ERG and gleason scorespecific metabolomic alterations in prostate cancer |
|
https://doi.org/10.18632/oncotarget.6370
Sebastian Meller, Hellmuth-A Meyer, Bianca Bethan, Dimo Dietrich, Sandra González Maldonado, Michael Lein, Matteo Montani, Regina Reszka, Philipp Schatz, Erik Peter, Carsten Stephan, Klaus Jung, Beate Kamlage, and Glen Kristiansen
|
| 1421-1438 |
|
| ERK8 is a novel HuR kinase that regulates tumour suppressor PDCD4 through a miR21 dependent mechanism |
|
https://doi.org/10.18632/oncotarget.6363
Urszula Liwak-Muir, Christine C. Dobson, Thet Naing, Quinlan Wylie, Lucia Chehade, Stephen D. Baird, Pranesh K. Chakraborty, and Martin Holcik
|
| 1439-1450 |
|
| Targeting the EWSETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma |
|
https://doi.org/10.18632/oncotarget.6385
Tim Hensel, Chiara Giorgi, Oxana Schmidt, Julia Calzada-Wack, Frauke Neff, Thorsten Buch, Felix K. Niggli, Beat W. Schäfer, Stefan Burdach, and Günther H.S. Richter
|
| 1451-1463 |
|
| Doublecortinlike kinase 1 expression associates with breast cancer with neuroendocrine differentiation |
|
https://doi.org/10.18632/oncotarget.6386
Yu-Hong Liu, Julia Y.S. Tsang, Yun-Bi Ni, Thazin Hlaing, Siu-Ki Chan, Kui-Fat Chan, Chun-Wai Ko, S. Shafaq Mujtaba, and Gary M. Tse
|
| 1464-1476 |
|
| Negative correlation of ITCH E3 ubiquitin ligase and miRNA106b dictates metastatic progression in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.6395
Zhu-lin Luo, Hui-jun Luo, Chen Fang, Long Cheng, Zhu Huang, Ruiwu Dai, Kun Li, Fu-zhou Tian, Tao Wang, and Li-jun Tang
|
| 1477-1485 |
|
| Prognostic impact of programmed cell death1 PD1 and PDligand 1 PDL1 expression in cancer cells and tumorinfiltrating lymphocytes in ovarian high grade serous carcinoma |
|
https://doi.org/10.18632/oncotarget.6429
Silvia Darb-Esfahani, Catarina Alisa Kunze, Hagen Kulbe, Jalid Sehouli, Stephan Wienert, Judith Lindner, Jan Budczies, Michael Bockmayr, Manfred Dietel, Carsten Denkert, Ioana Braicu, and Korinna Jöhrens
|
| 1486-1499 |
|
| The oncolytic virus dl922947 reduces IL8/CXCL8 and MCP1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma |
|
https://doi.org/10.18632/oncotarget.6430
Carmela Passaro, Francesco Borriello, Viviana Vastolo, Sarah Di Somma, Eloise Scamardella, Vincenzo Gigantino, Renato Franco, Gianni Marone, and Giuseppe Portella
|
| 1500-1515 |
|
| The antitumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction |
|
https://doi.org/10.18632/oncotarget.6399
Jean-Baptiste Oudart, Manon Doué, Alexia Vautrin, Bertrand Brassart, Christèle Sellier, Aurelie Dupont-Deshorgue, Jean-Claude Monboisse, François-Xavier Maquart, Sylvie Brassart-Pasco, and Laurent Ramont
|
| 1516-1528 |
|
| Critical role of PPARγ in myeloidderived suppressor cellstimulated cancer cell proliferation and metastasis |
|
https://doi.org/10.18632/oncotarget.6414
Ting Zhao, Hong Du, Janice S. Blum, and Cong Yan
|
| 1529-1543 |
|
| Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGFβ1 signaling pathway |
|
https://doi.org/10.18632/oncotarget.6441
Sangmin Kim, Jeongmin Lee, Myeongjin Jeon, Jeong Eon Lee, and Seok Jin Nam
|
| 1544-1558 |
|
| microRNA20a in human faeces as a noninvasive biomarker for colorectal cancer |
|
https://doi.org/10.18632/oncotarget.6403
Tung On Yau, Chung Wah Wu, Ceen-Ming Tang, Yingxuan Chen, Jingyuan Fang, Yujuan Dong, Qiaoyi Liang, Simon Siu Man Ng, Francis Ka Leung Chan, Joseph Jao Yiu Sung, and Jun Yu
|
| 1559-1568 |
|
| The pepper’s natural ingredient capsaicin induces autophagy blockage in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.6415
Ãgata Ramos-Torres, Alicia Bort, Cecilia Morell, Nieves RodrÃguez-Henche, and Inés DÃaz-Laviada
|
| 1569-1583 |
|
| miR382 targeting PTENAkt axis promotes liver regeneration |
|
https://doi.org/10.18632/oncotarget.6444
Yihua Bei, Yang Song, Fei Wang, Jasmina Dimitrova-Shumkovska, Yang Xiang, Yingying Zhao, Jingqi Liu, Junjie Xiao, and Changqing Yang
|
| 1584-1597 |
|
| Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma |
|
https://doi.org/10.18632/oncotarget.6408
Vishnu C. Ramani, Fenghuang Zhan, Jianbo He, Paola Barbieri, Alessandro Noseda, Guido Tricot, and Ralph D. Sanderson
|
| 1598-1607 |
|
| ROR functions as a ceRNA to regulate Nanog expression by sponging miR145 and predicts poor prognosis in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.6450
Song Gao, Peng Wang, Yongqiang Hua, Hao Xi, Zhiqiang Meng, Te Liu, Zhen Chen, and Luming Liu
|
| 1608-1618 |
|
| Ginsenoside Rg3 inhibits epithelialmesenchymal transition EMT and invasion of lung cancer by downregulating FUT4 |
|
https://doi.org/10.18632/oncotarget.6451
Lili Tian, Dachuan Shen, Xiaodong Li, Xiu Shan, Xiaoqi Wang, Qiu Yan, and Jiwei Liu
|
| 1619-1632 |
|
| NFY activates genes of metabolic pathways altered in cancer cells |
|
https://doi.org/10.18632/oncotarget.6453
Paolo Benatti, Maria Luisa Chiaramonte, Mariangela Lorenzo, John A. Hartley, Daniel Hochhauser, Nerina Gnesutta, Roberto Mantovani, Carol Imbriano, and Diletta Dolfini
|
| 1633-1650 |
|
| Therapeutic effect of TMZPOH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation |
|
https://doi.org/10.18632/oncotarget.6410
Li Xie, Xingguo Song, Wei Guo, Xingwu Wang, Ling Wei, Yang Li, Liyan Lv, Weijun Wang, Thomas C. Chen, and Xianrang Song
|
| 1651-1662 |
|
| The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression |
|
https://doi.org/10.18632/oncotarget.6411
Yu-Ting Huang, Qiang Lan, Lionel Ponsonnet, Marisa Blanquet, Gerhard Christofori, Jelena Zaric, and Curzio Rüegg
|
| 1663-1674 |
|
| Apoptosis induced by a HIPK2 fulllengthspecific siRNA is due to offtarget effects rather than prevalence of HIPK2Δe8 isoform |
|
https://doi.org/10.18632/oncotarget.6423
Giuliana Di Rocco, Alessandra Verdina, Veronica Gatti, Ilaria Virdia, Gabriele Toietta, Matilde Todaro, Giorgio Stassi, and Silvia Soddu
|
| 1675-1686 |
|
| Human Tcell leukemia virus type1encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1 |
|
https://doi.org/10.18632/oncotarget.6424
Diana G. Wright, Claire Marchal, Kimson Hoang, John A. Ankney, Stephanie T. Nguyen, Amanda W. Rushing, Nicholas Polakowski, Benoit Miotto, and Isabelle Lemasson
|
| 1687-1706 |
|
| Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast |
|
https://doi.org/10.18632/oncotarget.6421
Zoran Gatalica, Semir Vranic, Anatole Ghazalpour, Joanne Xiu, Idris Tolgay Ocal, John McGill, Ryan P. Bender, Erin Discianno, Aaron Schlum, Souzan Sanati, Juan Palazzo, Sandeep Reddy, and Barbara Pockaj
|
| 1707-1716 |
|
| Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma |
|
https://doi.org/10.18632/oncotarget.6435
Anna Trzeciecka, Szymon Klossowski, Malgorzata Bajor, Radoslaw Zagozdzon, Pawel Gaj, Angelika Muchowicz, Agata Malinowska, Anna Czerwoniec, Joanna Barankiewicz, Antoni Domagala, Justyna Chlebowska, Monika Prochorec-Sobieszek, Magdalena Winiarska, Ryszard Ostaszewski, Iwonna Gwizdalska, Jakub Golab, Dominika Nowis, and Malgorzata Firczuk
|
| 1717-1731 |
|
| Molecular analyses reveal close similarities between small cell carcinoma of the ovary hypercalcemic type and atypical teratoid/rhabdoid tumor |
|
https://doi.org/10.18632/oncotarget.6459
Somayyeh Fahiminiya, Leora Witkowski, Javad Nadaf, Jian Carrot-Zhang, Catherine Goudie, Martin Hasselblatt, Pascal Johann, Marcel Kool, Ryan S. Lee, Tenzin Gayden, Charles W. M. Roberts, Jaclyn A. Biegel, Nada Jabado, Jacek Majewski, and William D. Foulkes
|
| 1732-1740 |
|
| Epigenetic regulation of ZEB1RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatmentresistant breast cancer |
|
https://doi.org/10.18632/oncotarget.6480
Mariko Kikuchi, Keishi Yamashita, Mina Waraya, Naoko Minatani, Hideki Ushiku, Ken Kojo, Akira Ema, Yoshimasa Kosaka, Hiroshi Katoh, Norihiko Sengoku, Takumo Enomoto, Hirokazu Tanino, Masakazu Sawanobori, and Masahiko Watanabe
|
| 1741-1753 |
|
| Protein phosphatase 1 suppresses androgen receptor ubiquitylation and degradation |
|
https://doi.org/10.18632/oncotarget.6434
Xiaming Liu, Weiwei Han, Sarah Gulla, Nicholas I. Simon, Yanfei Gao, Changmeng Cai, Hongmei Yang, Xiaoping Zhang, Jihong Liu, Steven P. Balk, and Shaoyong Chen
|
| 1754-1764 |
|
| Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth |
|
https://doi.org/10.18632/oncotarget.6426
Florence Polet, Cyril Corbet, Adan Pinto, Laila Illan Rubio, Ruben Martherus, Vanesa Bol, Xavier Drozak, Vincent Grégoire, Olivier Riant, and Olivier Feron
|
| 1765-1776 |
|
| Targeting oncogenic PLCE1 by miR145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.6499
Xiao-Bin Cui, Su Li, Ting-Ting Li, Hao Peng, Ting-Ting Jin, Shu-Mao Zhang, Chun-Xia Liu, Lan Yang, Yao-Yuan Shen, Shu-Gang Li, Na Li, Yong Li, Jian-Ming Hu, Jin-Fang Jiang, Jing Suo, Yan Qi, Wei-Hua Liang, Liang-Hai Wang, Hong-Wei Dang, Li Li, Wei-Wei Cao, Yutao Wei, Laibo -Yin, Chuan-Yue Wu, Xiang-Lin Yuan, Hong Zhou, Yu Zheng, Yun-Zhao Chen, and Feng Li
|
| 1777-1795 |
|
| Nonepigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability |
|
https://doi.org/10.18632/oncotarget.6427
Min-Wu Chao, Po-Chen Chu, Hsiao-Ching Chuang, Fang-Hsiu Shen, Chih-Chien Chou, En-Chi Hsu, Lauren E. Himmel, Han-Li Huang, Huang-Ju Tu, Samuel K. Kulp, Che-Ming Teng, and Ching-Shih Chen
|
| 1796-1807 |
|
| MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion |
|
https://doi.org/10.18632/oncotarget.6577
Sara Mariotti, Ivana Barravecchia, Carla Vindigni, Angela Pucci, Michele Balsamo, Rosaliana Libro, Vera Senchenko, Alexey Dmitriev, Emanuela Jacchetti, Marco Cecchini, Franco Roviello, Michele Lai, Vania Broccoli, Massimiliano Andreazzoli, Chiara M. Mazzanti, and Debora Angeloni
|
| 1808-1825 |
|
| Griffipavixanthone a dimeric xanthone extracted from edible plants inhibits tumor metastasis and proliferation via downregulation of the RAF pathway in esophageal cancer |
|
https://doi.org/10.18632/oncotarget.6484
Zhijie Ding, Yuanzhi Lao, Hong Zhang, Wenwei Fu, Lunlun Zhu, Hongsheng Tan, and Hongxi Xu
|
| 1826-1837 |
|
| A versatile ex vivo technique for assaying tumor angiogenesis and microglia in the brain |
|
https://doi.org/10.18632/oncotarget.6550
Ali Ghoochani, Eduard Yakubov, Tina Sehm, Zheng Fan, Stefan Hock, Michael Buchfelder, Ilker Y. Eyüpoglu, and Nicolai Savaskan
|
| 1838-1853 |
|
| Serum cyclindependent kinase 9 is a potential biomarker of atherosclerotic inflammation |
|
https://doi.org/10.18632/oncotarget.6443
Yeming Han, Shanshan Zhao, Yaoqin Gong, Guihua Hou, Xi Li, and Li Li
|
| 1854-1862 |
|
| A method for quantification of exportin1 XPO1 occupancy by Selective Inhibitor of Nuclear Export SINE compounds |
|
https://doi.org/10.18632/oncotarget.6495
Marsha L. Crochiere, Erkan Baloglu, Boris Klebanov, Scott Donovan, Diego del Alamo, Margaret Lee, Michael Kauffman, Sharon Shacham, and Yosef Landesman
|
| 1863-1877 |
|
| Low β2adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism |
|
https://doi.org/10.18632/oncotarget.6479
Peder Rustøen Braadland, Helene Hartvedt Grytli, Håkon Ramberg, Betina Katz, Ralf Kellman, Louis Gauthier-Landry, Ladan Fazli, Kurt Allen Krobert, Wanzhong Wang, Finn Olav Levy, Anders Bjartell, Viktor Berge, Paul S. Rennie, Gunnar Mellgren, Gunhild Mari Mælandsmo, Aud Svindland, Olivier Barbier, and Kristin Austlid Taskén
|
| 1878-1894 |
|
| Genomewide identification of Wig1 mRNA targets by RIPSeq analysis |
|
https://doi.org/10.18632/oncotarget.6557
Cinzia Bersani, Mikael Huss, Stefania Giacomello, Li-Di Xu, Julie Bianchi, Sofi Eriksson, Fredrik Jerhammar, Andrey Alexeyenko, Anna Vilborg, Joakim Lundeberg, Weng-Onn Lui, and Klas G. Wiman
|
| 1895-1911 |
|
| Forkhead transcription factor FoxF1 interacts with Fanconi anemia protein complexes to promote DNA damage response |
|
https://doi.org/10.18632/oncotarget.6422
Arun Pradhan, Vladimir Ustiyan, Yufang Zhang, Tanya V. Kalin, and Vladimir V. Kalinichenko
|
| 1912-1926 |
|
| Dynamic reprogramming of DNA methylation in SETD2deregulated renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.6481
Rochelle L. Tiedemann, Ryan A. Hlady, Paul D. Hanavan, Douglas F. Lake, Raoul Tibes, Jeong-Heon Lee, Jeong-Hyeon Choi, Thai H. Ho, and Keith D. Robertson
|
| 1927-1946 |
|
| ATRChk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer |
|
https://doi.org/10.18632/oncotarget.6482
Ching-Chia Li, Juan-Cheng Yang, Mei-Chin Lu, Chia-Lin Lee, Chieh-Yu Peng, Wei-Yu Hsu, Yun-Hao Dai, Fang-Rong Chang, Da-Yong Zhang, Wen-Jeng Wu, and Yang-Chang Wu
|
| 1947-1959 |
|
| MethylCpGbinding domain sequencing reveals a prognostic methylation signature in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.6477
Anneleen Decock, Maté Ongenaert, Robrecht Cannoodt, Kimberly Verniers, Bram De Wilde, Geneviève Laureys, Nadine Van Roy, Ana P. Berbegall, Julie Bienertova-Vasku, Nick Bown, Nathalie Clément, Valérie Combaret, Michelle Haber, Claire Hoyoux, Jayne Murray, Rosa Noguera, Gaelle Pierron, Gudrun Schleiermacher, Johannes H. Schulte, Ray L. Stallings, Deborah A. Tweddle, for the Children’s Cancer and Leukaemi Group (CCLG), Katleen De Preter, Frank Speleman, and Jo Vandesompele
|
| 1960-1972 |
|
| Extensive regulation of nicotinate phosphoribosyltransferase NAPRT expression in human tissues and tumors |
|
https://doi.org/10.18632/oncotarget.6538
Sara Duarte-Pereira, Isabel Pereira-Castro, Sarah S. Silva, Mariana Gonçalves Correia, Célia Neto, LuÃs Teixeira da Costa, António Amorim, and Raquel M. Silva
|
| 1973-1983 |
|
| Autophagy induction causes a synthetic lethal sensitization to ribonucleotide reductase inhibition in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.6539
Yun-Ru Chen, Brittany Tsou, Shuya Hu, Huimin Ma, Xiyong Liu, Yun Yen, and David K. Ann
|
| 1984-1999 |
|
| Metformin may reduce oral cancer risk in patients with type 2 diabetes |
|
https://doi.org/10.18632/oncotarget.6626
Chin-Hsiao Tseng
|
| 2000-2008 |
|
| Connexin 32 dysfunction promotes ethanolrelated hepatocarcinogenesis via activation of Dusp1Erk axis |
|
https://doi.org/10.18632/oncotarget.6511
Hiroyuki Kato, Aya Naiki-Ito, Taku Naiki, Shugo Suzuki, Yoriko Yamashita, Shinya Sato, Hiroyuki Sagawa, Akihisa Kato, Toshiya Kuno, and Satoru Takahashi
|
| 2009-2021 |
|
| MULTIMERIN2 binds VEGFA primarily via the carbohydrate chains exerting an angiostatic function and impairing tumor growth |
|
https://doi.org/10.18632/oncotarget.6515
Roberta Colladel, Rosanna Pellicani, Eva Andreuzzi, Alice Paulitti, Giulia Tarticchio, Federico Todaro, Alfonso Colombatti, and Maurizio Mongiat
|
| 2022-2037 |
|
| Loss of 11βHSD1 enhances glycolysis facilitates intrahepatic metastasis and indicates poor prognosis in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.6661
Xu Liu, Xiao-long Tan, Meng Xia, Chao Wu, Jia Song, Jing-jing Wu, Arian Laurence, Qing-guo Xie, Ming-zhi Zhang, Hui-fang Liang, Bi-xiang Zhang, and Xiao-ping Chen
|
| 2038-2053 |
|
| Human βdefensin 3 contains an oncolytic motif that binds PI45P2 to mediate tumour cell permeabilisation |
|
https://doi.org/10.18632/oncotarget.6520
Thanh Kha Phan, Fung T. Lay, Ivan K.H. Poon, Mark G. Hinds, Marc Kvansakul, and Mark D. Hulett
|
| 2054-2069 |
|
| Enhancement of antileukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cellinduced NK cell damage |
|
https://doi.org/10.18632/oncotarget.6529
Roberto Arriga, Sara Caratelli, Andrea Coppola, Giulio Cesare Spagnoli, Adriano Venditti, Sergio Amadori, Giulia Lanzilli, Davide Lauro, Patrizia Palomba, Tommaso Sconocchia, Maria Ilaria Del Principe, Luca Maurillo, Francesco Buccisano, Barbara Capuani, Soldano Ferrone, and Giuseppe Sconocchia
|
| 2070-2079 |
|
| The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma |
|
https://doi.org/10.18632/oncotarget.6712
David Y.A. Dadey, Vaishali Kapoor, Arpine Khudanyan, Fumihiko Urano, Albert H. Kim, Dinesh Thotala, and Dennis E. Hallahan
|
| 2080-2092 |
|
| AEG1 activates Wnt/PCP signaling to promote metastasis in tongue squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.6573
Yunping Pan, Xu Guo, Zheng Yang, Shan Chen, Yiyan Lei, Millicent Lin, Liantang Wang, Chongjin Feng, and Zunfu Ke
|
| 2093-2104 |
|
| The androgen receptor cytosineadenineguanine repeat length contributes to the development of epithelial ovarian cancer |
|
https://doi.org/10.18632/oncotarget.6012
Xiangrui Meng, Peng Lu, Zhi Chu, and Qingxia Fan
|
| 2105-2112 |
|
| Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.6017
Jie Ma, Xiao Tang, Wen-wen Sun, Ying Liu, Yi-ran Tan, Hai-long Ma, Dong-wang Zhu, Min Wang, Li-zhen Wang, Jiang Li, Yao-yao Tu, Chen-ping Zhang, Zhi-yuan Zhang, and Lai-ping Zhong
|
| 2113-2122 |
|
| A prognostic classifier for patients with colorectal cancer liver metastasis based on AURKA PTGS2 and MMP9 |
|
https://doi.org/10.18632/oncotarget.6188
Jeroen A.C.M. Goos, Veerle M.H. Coupé, Mark A. van de Wiel, Begoña Diosdado, Pien M. Delis-Van Diemen, Annemieke C. Hiemstra, Erienne M.V. de Cuba, Jeroen A.M. Beliën, C. Willemien Menke - van der Houven van, Albert A. Geldof, Gerrit A. Meijer, Otto S. Hoekstra, and Remond J.A. Fijneman on behalf of the DeCoDe PET Group
|
| 2123-2134 |
|
| Prognostic impact of EpsteinBarr virus EBVDNA copy number at diagnosis in chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.6281
Jin-Hua Liang, Rui Gao, Yi Xia, Robert Peter Gale, Rui-Ze Chen, Yu-Qiong Yang, Li Wang, Xiao-Yan Qu, Hai-Rong Qiu, Lei Cao, Min Hong, Rong Wang, Yan Wang, Lei Fan, Yao-Yu Chen, Zhi-Bin Hu, Jian-Yong Li, and Wei Xu
|
| 2135-2142 |
|
| Relationship of Oct4 to malignant stage: a metaanalysis based on 502 positive/high Oct4 cases and 522 negative/low casefree controls |
|
https://doi.org/10.18632/oncotarget.5737
Beilong Zhong, Yan Lin, Yingrong Lai, Fangfang Zheng, Xiaobin Zheng, Rijiao Huang, Weilin Yang, and Zhenguang Chen
|
| 2143-2152 |
|
| Erratum: PBK/TOPK enhances aggressive phenotype in prostate cancer via βcateninTCF/LEFmediated matrix metalloproteinases production and invasion |
|
https://doi.org/10.18632/oncotarget.6865
Joshua D. Brown-Clay, Deepika N. Shenoy, Olga Timofeeva, Bhaskar V. Kallakury, Asit K. Nandi, and Partha P. Banerjee
|
| 2153-2154 |
